Adaptive Biotechnologies Corp (ADPT)
2.40
+0.06
(+2.78%)
USD |
NASDAQ |
Apr 19, 12:16
Adaptive Biotechnologies Total Liabilities (Quarterly): 352.86M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 352.86M |
| September 30, 2023 | 356.04M |
| June 30, 2023 | 368.57M |
| March 31, 2023 | 367.51M |
| December 31, 2022 | 392.52M |
| September 30, 2022 | 396.39M |
| June 30, 2022 | 288.32M |
| March 31, 2022 | 304.94M |
| December 31, 2021 | 319.24M |
| September 30, 2021 | 341.06M |
| June 30, 2021 | 340.06M |
| Date | Value |
|---|---|
| March 31, 2021 | 346.38M |
| December 31, 2020 | 373.15M |
| September 30, 2020 | 320.43M |
| June 30, 2020 | 324.88M |
| March 31, 2020 | 323.32M |
| December 31, 2019 | 341.26M |
| September 30, 2019 | 331.47M |
| June 30, 2019 | 885.77M |
| March 31, 2019 | 326.49M |
| December 31, 2018 | 590.80M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
288.32M
Minimum
Jun 2022
885.77M
Maximum
Jun 2019
372.33M
Average
341.26M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Ampio Pharmaceuticals Inc | 2.376M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 661.13M |
| Shareholders Equity (Quarterly) | 308.40M |
| Current Ratio | 4.660 |